Implantable cardioverterdefibrillators in France: Practices and regional variability

Europace

Volumn 13, Issue 11, 2011, Pages 1568-1573

  Lazarus, Arnaud ^a   Biondi, Nelly ^b   Thbaut, Jean Franois ^c   Durand Zaleski, Isabelle ^b,d   Chauvin, Michel ^e  

^a InParys   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c URPS Ile de France   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e HÔPITAL CIVIL   (France)

Author keywords

Implantable cardioverterdefibrillator; Medical device registry; Public health; Sudden cardiac death; Ventricular tachyarrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGIST; DEFIBRILLATOR; DISEASE REGISTRY; FEMALE; FRANCE; HEART DISEASE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIMARY PREVENTION; PRIORITY JOURNAL; REGIONALIZATION; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL PRACTICE; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; REGISTER; RETROSPECTIVE STUDY; STATISTICS; SUDDEN DEATH; UTILIZATION REVIEW;

AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FRANCE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 80054882423     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur238     Document Type: Article

References (23)

1. Ezekowitz JA, Amstrong PW, MacAlister FA. Implantable cardioverter-defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-52.
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-natal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
3. Conolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter-defibrillator against amiodarone. Circulation 2000;101:1297-302. (Pubitemid 30158618)
4. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. (Pubitemid 30648765)
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
7. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. MADIT-II Investigators. Analysis of mortality events in the Multicenter automatic defibrillator implantation trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65.
8. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA et al. SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135-42. (Pubitemid 44420745)
9. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-50.
10. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
11. Alzueta J, Linde A, Barrera A, Peña J, Peinado R. Spanish Implantable Cardioverter-Defibrillator Registry. Sixth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter- Defibrillators (2009). Rev Esp Cardiol 2010;63:1468-81.
12. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: Data from the Italian ICD Registry for the years 2005-07. Europace 2009;11: 465-75.
13. Danish Pacemaker and ICD Registry 2007 Annual Report. http://pacemaker.dk
14. Da Silva MN, Bonhorst D, De Sousa J. National registry on cardiac electrophysiology 2007 and 2008. Rev Port Cardiol 2009;28:1291-306.
15. Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 2009;6:1397-401.
16. Van Brahandt H, Thiry N, Neyt M, Van den Oever R, Galloo P, Vanoverloop J et al. The implantable cardioverter-defibrillator: A Health Technology Assessment. KCE Reports 58C. Belgian Health Care Knowledge Centre 2007:85-117. http://www.kce.fgov.be/index-en.aspx?SGREF=5213&CREF=18664 (12 April 2011, date last accessed). http://www.kce.fgov.be/index-en.aspx?SGREF=5213&CREF= 18664 (12 April 2011, date last accessed).
17. Camm AJ, Nisam S. European utilization of the implantable defibrillator: Has 10 years changed the 'enigma'?. Europace 2010;12:1063-9.
18. Ovsyshcher IE, Furman S. Determinants of geographic variations in pacemakers and implantable cardioverter-defibrillators implantations rates. Pacing Clin Electrophysiol 2003;26:474-8. (Pubitemid 36399198)
19. Shab B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC et al. Get With The Guidelines Steering Committee. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: Data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol 2009;53:416-22.
20. Vardas P, Auricchio A, Wolpert C. The EHRA White Book 2010. The Current Status of Cardiac Electrophysiology in ESC Member Countries. (2010) European Society of Cardiology
21. Vardas P, Auricchio A, Wolpert C. The EHRA White Book 2010. The Current Status of Cardiac Electrophysiology in ESC Member Countries. 2010, European Society of Cardiology. 21. Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C et al A review of the evidence on the effects and costs of implantable cardioverter-defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Health Technol Assess 2006; 10(27):iii-iv, ix-xi, 1-164.
22. EUCOMED. Statistics for cardiac rhythm management products, 2005-2009. [Internet] 2009 [cited 2011 Apr 12]. http://www.eucomed.org/uploads/-medical- technology/facts-figures/110302-statistics-for-cardiac-rhythm-management- products-20052009.pdf; (12 April 2011, date last accessed).
23. Nielsen JC. National registry data on implantable cardioverter- defibrillator treatment: What are they useful for? Europace 2009;11:405-6.